At this time, posts about iCure are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 4,393 shares of iCure, and institutions have purchased a net 13,000 shares. iCure is known as a company possessing core technology for transdermal drug delivery systems.


As of 1:31 PM on the 16th, iCure's stock price is 79,500 KRW, up 1.4% from the previous day, with a trading volume of 713,853 shares, which is 113.98% of the 5-day average trading volume.


In addition to iCure, posts by investors are also rapidly increasing for Mirae I&IG (007120), Shinpoong Paper (002870), and IA (038880).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing